Humedix Co Ltd (200670) - Cash Flow Conversion Efficiency

Latest as of June 2026: 0.019x

Based on the latest financial reports, Humedix Co Ltd (200670) has a cash flow conversion efficiency ratio of 0.019x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩5.71 Billion ≈ $3.87 Million USD) by net assets (₩308.15 Billion ≈ $208.83 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Humedix Co Ltd market cap and net worth for the company's overall valuation and market capitalisation.

Humedix Co Ltd - Cash Flow Conversion Efficiency Trend (2015–2025)

This chart illustrates how Humedix Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Humedix Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Humedix Co Ltd ranked by their cash flow conversion efficiency. Explore 200670 cash to earnings ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Rico Auto Industries Limited NSE:RICOAUTO	0.190x
Formosa Oilseed Processing Co Ltd TW:1225	-0.011x
SOL-GEL TECHN. IS-10 F:4SG	N/A
Iron Force Industrial Co Ltd TW:2228	0.080x
SHIPPING CORPORATION OF INDIA LAND NSE:SCILAL	-0.005x
Ag Growth International Inc TO:AFN	-0.005x
ANGI Homeservices Inc NASDAQ:ANGI	0.040x
Prosafe SE OL:PRS	-0.021x

Annual Cash Flow Conversion Efficiency for Humedix Co Ltd (2015–2025)

The table below shows the annual cash flow conversion efficiency of Humedix Co Ltd from 2015 to 2025. View 200670 stock price and chart for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩299.59 Billion ≈ $203.03 Million	₩45.15 Billion ≈ $30.59 Million	0.151x	-32.13%
2024-12-31	₩228.53 Billion ≈ $154.87 Million	₩50.74 Billion ≈ $34.39 Million	0.222x	+42.39%
2023-12-31	₩198.06 Billion ≈ $134.22 Million	₩30.89 Billion ≈ $20.93 Million	0.156x	-43.14%
2022-12-31	₩139.11 Billion ≈ $94.27 Million	₩38.15 Billion ≈ $25.86 Million	0.274x	+80.11%
2021-12-31	₩125.99 Billion ≈ $85.38 Million	₩19.18 Billion ≈ $13.00 Million	0.152x	-23.06%
2020-12-31	₩120.07 Billion ≈ $81.37 Million	₩23.76 Billion ≈ $16.10 Million	0.198x	+60.66%
2019-12-31	₩112.10 Billion ≈ $75.97 Million	₩13.81 Billion ≈ $9.36 Million	0.123x	-45.07%
2018-12-31	₩106.13 Billion ≈ $71.93 Million	₩23.80 Billion ≈ $16.13 Million	0.224x	+176.11%
2017-12-31	₩107.92 Billion ≈ $73.13 Million	₩8.77 Billion ≈ $5.94 Million	0.081x	+16.47%
2016-12-31	₩109.11 Billion ≈ $73.94 Million	₩7.61 Billion ≈ $5.16 Million	0.070x	-34.59%
2015-12-31	₩109.80 Billion ≈ $74.41 Million	₩11.71 Billion ≈ $7.93 Million	0.107x	--

About Humedix Co Ltd

KQ:200670 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$188.10 Million

₩277.56 Billion KRW

Market Cap Rank

#16855 Global

#647 in Korea

Share Price

₩25000.00

Change (1 day)

-2.72%

52-Week Range

₩22600.00 - ₩66300.00

All Time High

₩75800.00